Product Information
EZETIMIBE-SIMVASTATIN 10-10 MG is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.3810 per EA under NDC 68462032190. Its NADAC has been published 312 times since Jul 8, 2020.
Strength
10; 10 mg/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462032190
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EZETIMIBE; SIMVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA208699On Market Since
6/27/2019
Pharmacological Classes
Price Statistics
The NADAC for EZETIMIBE-SIMVASTATIN 10-10 MG has been published 312 times since Jul 8, 2020, and over the history we have for it it has declined 74.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3810 per EA |
|---|---|
| All-time high | $1.7793 (Sep 16, 2020) |
| All-time low | $0.2356 (Apr 19, 2023) |
| 52-week high | $0.3810 |
| 52-week low | $0.2639 |
| Median price | $0.4440 |
| Average price | $0.6002 |
| Largest weekly change | +75.7% (May 17, 2023) |
| Weeks tracked | 312 |
| Tracking since | Jul 8, 2020 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EZETIMIBE-SIMVASTATIN 10-10 MG?
The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE-SIMVASTATIN 10-10 MG, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.3810 per EA (NDC 68462032190), effective Jun 24, 2026.
How has the price of EZETIMIBE-SIMVASTATIN 10-10 MG changed over time?
Over the history we have for it, the NADAC for EZETIMIBE-SIMVASTATIN 10-10 MG has declined 74.6%. It has been tracked across 312 weekly CMS publications since Jul 8, 2020.
What are the highest and lowest recorded NADAC prices for EZETIMIBE-SIMVASTATIN 10-10 MG?
Since Jul 8, 2020, the NADAC for EZETIMIBE-SIMVASTATIN 10-10 MG has ranged from a low of $0.2356 (Apr 19, 2023) to a high of $1.7793 (Sep 16, 2020), with a median of $0.4440 per EA.
Are there cheaper alternatives to EZETIMIBE-SIMVASTATIN 10-10 MG?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, EZETIMIBE-SIMVASTATIN 10-10 MG, is $0.3188 per EA — about 16% below EZETIMIBE-SIMVASTATIN 10-10 MG.
Who manufactures EZETIMIBE-SIMVASTATIN 10-10 MG?
EZETIMIBE-SIMVASTATIN 10-10 MG (NDC 68462032190) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification